Does science advance one funeral at a time, researchers ask

BY  
Since the 1950s, productivity is down in biomedical and pharmaceutical development, according to healthcare industry experts. The Brookings Institution recently explored possible causes for this decline and ways to remedy it. Photo by Reuters

When a star scientist dies, outsiders often tackle mainstream questions in the field by leveraging new ideas that arise in other domains, a new working paper from the National Bureau of Economic Research finds. Photo by Reuters

Editor’s Note: For 31 years now, Paul Solman’s reports on the NewsHour have aimed to make sense of economic news and research for a general audience. Since 2007, our Making Sen$e page has vowed to do the same, turning to leading academics and thinkers in the fields of business and economics to help explain what’s interesting and relevant about their work. That includes reports and interviews with economists affiliated with the National Bureau of Economic Research.

Making Sense/NBER logo

Each month, the NBER Digest summarizes several recent NBER working papers. These papers have not been peer-reviewed, but are circulated by their authors for comment and discussion. With the NBER’s blessing, Making Sen$e is pleased to feature these summaries regularly on our page.

The following summary was written by the NBER and doesn’t necessarily reflect the views of Making Sen$e.


Knowledge accumulation — the process by which new research builds upon prior research — is central to scientific progress, but the way this process works is not well understood.

In “Does Science Advance One Funeral at a Time?” Pierre AzoulayChristian Fons-Rosen and Joshua S. Graff Zivin explore the famous quip by physicist Max Planck. They show that the premature deaths of elite scientists affect the dynamics of scientific discovery. Following such deaths, scientists who were not collaborators with the deceased stars become more visible, and they advance novel ideas through increased publications within the field of the deceased star. These emerging stars are often scientists who were not previously active within that field. The results suggest that outsiders to a specific scientific field are reluctant to challenge a research star who is viewed as a leader within that field.

The death of a star scientist nber

The authors tracked the publication records of scientists — both collaborators and noncollaborators — before and after a research superstar died. To narrow the scope of their study, they focused on academics in the life sciences, a sector which is heavily supported by National Institutes of Health funding and produces a high volume of research. They established a list of 12,935 elite scientists using criteria such as the amount of research funding received, publication citations, number of patents, membership in prestigious organizations, career awards and prizes. They then examined records of 452 of those elite scientists who died prematurely — before retiring or becoming administrators — between 1975 and 2003. Publication data was gathered from the National Library of Medicine’s PubMed service, which indexes and tracks articles by research topics, names of authors and coauthors, citations, related articles and other information from 40,000 publications.

The findings confirm previous work showing that the number of articles by collaborators decreased substantially — by about 40 percent — after the death of a star scientist. Publication activity by noncollaborators increased by an average of 8 percent after the death of an elite scientist. By five years after the death, this activity of noncollaborators fully offset the productivity decline of collaborators. “These additional contributions are disproportionately likely to be highly cited,” the researchers found. “They are also more likely to be authored by scientists who were not previously active in the deceased superstar’s field.”

Few of the deceased scientists served as editors of academic journals or on committees overseeing the issuance of research grants, so the researchers rule out the possibility that the deceased scientists used their influence to limit who could or could not publish their work or receive grants within their field. Instead, they say, the evidence suggests that outsiders were reluctant to challenge the leadership within research areas in which an elite scientist was active. While entry occurs after a star’s passing, it is not monolithic. Key collaborators left behind can regulate entry into the field through the control of intellectual, social and resource barriers.

“While coauthors suffer after the passing of a superstar, it is not simply the case that star scientists in a competing lab assume the leadership mantle,” the authors conclude. “Rather, the boost comes largely from outsiders who appear to tackle the mainstream questions within the field but by leveraging newer ideas that arise in other domains. This intellectual arbitrage is quite successful — the new articles represent substantial contributions, at least as measured by long-run citation impact.”

— Jay Fitzgerald, National Bureau of Economic Research

SHARE VIA TEXT